| __timestamp | Merck & Co., Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 382096000000 |
| Thursday, January 1, 2015 | 6704000000 | 345927000000 |
| Friday, January 1, 2016 | 7194000000 | 312303000000 |
| Sunday, January 1, 2017 | 9982000000 | 325441000000 |
| Monday, January 1, 2018 | 9752000000 | 368298000000 |
| Tuesday, January 1, 2019 | 9872000000 | 492381000000 |
| Wednesday, January 1, 2020 | 13397000000 | 455833000000 |
| Friday, January 1, 2021 | 12245000000 | 526087000000 |
| Saturday, January 1, 2022 | 13548000000 | 633325000000 |
| Sunday, January 1, 2023 | 30531000000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, innovation is the lifeblood that drives progress and success. Over the past decade, Merck & Co., Inc. and Takeda Pharmaceutical Company Limited have been at the forefront of this innovation race. From 2014 to 2023, Merck's R&D expenses have shown a steady increase, peaking in 2023 with a remarkable 330% growth compared to 2014. Meanwhile, Takeda's investment in research and development has consistently outpaced Merck's, with a staggering 91% increase over the same period.
While Merck's R&D spending reached its zenith in 2023, Takeda's commitment to innovation remains unwavering, with 2023 marking its highest expenditure yet. This trend underscores the critical role of R&D in maintaining a competitive edge in the pharmaceutical sector. As we look to the future, these investments will likely shape the next wave of medical breakthroughs.
R&D Insights: How Merck & Co., Inc. and argenx SE Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Ascendis Pharma A/S
Merck & Co., Inc. or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Merck & Co., Inc. vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and argenx SE
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Genmab A/S
R&D Insights: How Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Geron Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Mesoblast Limited Allocate Funds